Clinical Trial Update: Biomarker Analysis of Tislelizumab Combined With Chemotherapy for Perioperative Treatment of G/GEJ Adenocarcinoma

View source ↗

Summary

Completed clinical trial update reporting biomarker analysis for the tislelizumab-chemotherapy combination as perioperative treatment for gastric and gastroesop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma
• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• Tislelizumab (tislelizumab)

Snippet

Sponsor: Xijing Hospital | Conditions: Locally Advanced Gastric Adenocarcinoma, PD-1 | Status: COMPLETED